Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK, Westbrook SD, Louden C et. al. The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy. Hindawi Publishing Corporation AIDS Research and Treatment. 2012. doi:10.1155/2012/ 262471
A. Borst, M. T. Raimer, D. W. Warnock, C. J. Morrison, and B. A. Arthington-Skaggs, “Rapid acquisition of stable azole resistance by Candida glabrataisolates obtained before the clinical introduction of fluconazole,” Antimicrobial Agents andChemotherapy. 2005; 49:783-787.
Katiraee F, Teifoori F, Soltani M. Emergence of azole-resistant Candida species in AIDS patients with oropharyngeal candidiasis in Iran. Curr Med Mycol. 2015;1:11-16.
W. R. Kirkpatrick, S. G.Revankar, R. K. McAtee, et al, “Detection of Candida dubliniensisin oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates,” Journal of Clinical Microbiology. 1998;36:3007-3012.
Anwar Khan P, Malik A, Subhan Khan H; Profile of candidiasis in HIV infected patients; Indian Journal of Microbiology. 2012;4:204-209.
Sharifzadeh A, Khosravi AR, Shokri H, Sharafi G. Antifungal effect of Trachyspermumammi against susceptible and fluconazole-resistant strains of Candida albicans. Journal De Mycologie Médicale. 2015.
